College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, P. R. China.
Small. 2023 Aug;19(35):e2301654. doi: 10.1002/smll.202301654. Epub 2023 Apr 25.
Enzymatic biofuel cells have become powerful tools in biosensing, which however generally suffer from the limited loading efficiency as well as low catalytic activity and poor stability of bioenzymes. Herein, the hierarchical porous metal-organic frameworks (MOFs) are synthesized using tannic acid (TA) for structural etching, which realizes co-encapsulation of glucose dehydrogenase (GDH) and nicotinamide adenine dinucleotide (NAD ) cofactor in zeolitic imidazolate framework (ZIF-L) and are further used as the biocatalytic microreactors to modify bioanode. In this work, the TA-controlled etching can not only expand the pore size of microreactors, but also achieve the reorientation of enzymes in their lower surface energy form, therefore enhancing the biocatalysis of cofactor-dependent enzyme. Meanwhile, the topological DNA tetrahedron is assembled on the microreactors, which acts as the microRNA-responsive "lock" to perform the cascade signal amplification of exonuclease III-assisted target recycling on bioanode and hybridization chain reaction (HCR) on biocathode. The proposed self-powered biosensor has achieved a detection limit as low as 2 aM (6 copies miRNA-21 in a 5 µL of sample), which is further successfully applied to identify cancer cells and clinical serums of breast cancer patients based on the different levels of miRNA-21, holding great potential in accurate disease identification and clinical diagnosis.
酶生物燃料电池已成为生物传感领域的有力工具,但它们通常受到生物酶的载量效率有限、催化活性低和稳定性差的限制。在此,使用单宁酸 (TA) 合成了分级多孔金属有机骨架 (MOFs),用于结构刻蚀,实现了葡萄糖脱氢酶 (GDH) 和烟酰胺腺嘌呤二核苷酸 (NAD) 辅酶共包封在沸石咪唑骨架 (ZIF-L) 中,并进一步用作生物催化微反应器来修饰生物阳极。在这项工作中,TA 控制的刻蚀不仅可以扩大微反应器的孔径,还可以实现酶在低表面能形式下的重新取向,从而增强了对辅酶依赖性酶的生物催化作用。同时,拓扑 DNA 四面体在微反应器上组装,作为微 RNA 响应的“锁”,在生物阳极上进行外切酶 III 辅助目标循环的级联信号放大,以及在生物阴极上进行杂交链式反应 (HCR)。所提出的自供电生物传感器的检测限低至 2 aM(5 µL 样本中 6 个 miRNA-21 拷贝),进一步成功应用于基于不同水平的 miRNA-21 识别癌细胞和乳腺癌患者的临床血清,在准确疾病识别和临床诊断方面具有巨大潜力。